Shield Therapeutics may receive forecast update following Accrufer application, says broker
Broker Peel Hunt has kept its rating on Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) under review following news that its Korean partner has filed a new...
Stay updated with breaking news from Shield Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Broker Peel Hunt has kept its rating on Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) under review following news that its Korean partner has filed a new...
HBM Healthcare Investments Ltd Bundesplatz 1, 6300 Zug Invitation to the 23rd Ordinary Shareholders' Meeting Monday,...
Investegate announcements from Hardman & Co: Shield Therapeutics (STX): Cash management is key
Hardman & Co Research Hardman & Co: Shield Therapeutics : Cash management is key 23-May-2024 / 07:15 GMT/BST The issuer is solely responsible for the content of this...
Hardman & Co Research Hardman & Co: Shield Therapeutics (STX): Cash management is key 23-May-2024 / 07:15 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman